Christopher Bowden, Chief Medical Officer at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 35,222 shares at $55.11 ($1.9M) on 2021-04-20, disclosed to the SEC on 2021-04-21.
Seasonal sale ($1.9M) by Chief Medical Officer — this insider has traded AGIO in April in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.16 | 3,210 | $177K | 9.1% |
| 2 | $55.16 | 3,210 | $177K | 9.1% |
| 3 | $55.11 | 14,401 | $794K | 40.9% |
| 4 | $55.11 | 14,401 | $794K | 40.9% |
| Total | $55.12 avg | 35,222 | $1.9M | 100% |
| Filing → |
| AGIO | SELL | 2021-06-11 | $3.4M | — | Filing → |
| AGIO | SELL | 2021-06-09 | $1.3M | — | Filing → |
| AGIO | SELL | 2020-05-21 | $358K | — | Filing → |